Thymosin Alpha-1 for Hepatitis B in Japanese Patients: Randomized Trial Shows Safety and Response
Thymosin alpha-1 demonstrated safety and virological response in Japanese chronic hepatitis B patients in a randomized clinical trial, validating its efficacy in an Asian population.
Quick Facts
What This Study Found
Thymosin alpha-1 showed safety and efficacy (HBeAg seroconversion, HBV DNA reduction) in Japanese chronic hepatitis B patients in a randomized controlled trial, validating immunotherapy-based HBV treatment in the high-prevalence Asian population.
Key Numbers
How They Did This
RCT study on thymosin-alpha-1, infection.
Why This Research Matters
Relevant for thymosin-alpha-1, infection, immune-function, clinical-trials.
The Bigger Picture
Advances peptide research with clinical implications.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding Thymosin alpha-1 showed safety and efficacy (HBeAg seroconversion, HBV DNA reduction) in Japanese chronic hepatitis B patients in a randomized control
- Evidence Grade:
- strong evidence.
- Study Age:
- Published in 2005.
- Original Title:
- The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial.
- Published In:
- Journal of viral hepatitis, 12(3), 300-6 (2005)
- Authors:
- Iino, S, Toyota, J, Kumada, H, Kiyosawa, K, Kakumu, S, Sata, M, Suzuki, H, Martins, E B
- Database ID:
- RPEP-01050
Evidence Hierarchy
Frequently Asked Questions
What was studied?
Thymosin Alpha-1 for Hepatitis B in Japanese Patients: Randomized Trial Shows Safety and Response
What was found?
Thymosin alpha-1 demonstrated safety and virological response in Japanese chronic hepatitis B patients in a randomized clinical trial, validating its efficacy in an Asian population.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01050APA
Iino, S; Toyota, J; Kumada, H; Kiyosawa, K; Kakumu, S; Sata, M; Suzuki, H; Martins, E B. (2005). The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial.. Journal of viral hepatitis, 12(3), 300-6.
MLA
Iino, S, et al. "The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial.." Journal of viral hepatitis, 2005.
RethinkPeptides
RethinkPeptides Research Database. "The efficacy and safety of thymosin alpha-1 in Japanese pati..." RPEP-01050. Retrieved from https://rethinkpeptides.com/research/iino-2005-the-efficacy-and-safety
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.